Wall Street brokerages predict that Benitec Biopharma Inc. (NASDAQ:BNTC – Get Rating) will announce earnings per share of ($0.44) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Benitec Biopharma’s earnings. Benitec Biopharma reported earnings per share of ($164.69) during the same quarter last year, which suggests a […]
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Rating) was the target of a large drop in short interest in February. As of February 28th, there was short interest totalling 10,700 shares, a drop of 17.1% from the February 13th total of 12,900 shares. Based on an average daily volume of 34,200 shares, the days-to-cover ratio is […]